Abstract |
A prospective experiment was carried out in 56 patients undergoing coronary artery revascularization to determine whether those having a glucose- insulin- potassium (GIK) perfusion during the procedure would have fewer myocardial infarctions (MI) compared with patients given a control perfusion of Normosol-R. Six patients (11%) developed an MI, defined as a 24-hour creatine phosphokinase MB isoenzyme value of 100 IU per liter or greater. Four (13%) had control perfusions and 2(8%) had GIK perfusion. One MI in a double-graft recipient who had GIK perfusion occurred because of a technical surgical error; therefore, the corrected MI rate was 13% in control patients compared with 4% for the GIK group. These data, as well as the more frequent spontaneous defibrillation in patients who had GIK perfusion, suggest that GIK was of benefit.
|
Authors | J F Ray 3rd, D A Tewksbury, W O Myers, F J Wenzel, R D Sautter |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 23
Pg. 14-9
(Jan 1977)
ISSN: 0003-4975 [Print] Netherlands |
PMID | 299803
(Publication Type: Journal Article)
|
Chemical References |
- Blood Glucose
- Insulin
- Glucose
- Potassium
|
Topics |
- Blood Glucose
(metabolism)
- Coronary Artery Bypass
- Coronary Vessels
(surgery)
- Glucose
(administration & dosage)
- Humans
- Insulin
(administration & dosage, blood)
- Myocardial Infarction
(prevention & control)
- Perfusion
- Potassium
(administration & dosage, blood)
- Time Factors
|